홈 › 흑색종 › 플로리다

플로리다의 흑색종 임상 시험

흑색종 관련 연구 55개가 플로리다 내 여러 지역에서 참여자를 모집하고 있습니다.

플로리다의 도시

공식 연구 텍스트(영어)

A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)

Mayo Clinic Florida, Jacksonville
Boca Raton Clinical Research (BRCR) Global, Tamarac
H. Lee Moffitt Cancer Center, Tampa

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06246916

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

AdventHealth Medical Group Oncology Research at Celebration, Kissimmee

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06172478

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

Mayo Clinic in Florida, Jacksonville

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT05136196

DESTINY-PANTUMOUR04

Research Site, Coral Springs
Research Site, St. Petersburg
Research Site, West Palm Beach

피험자 모집 중관찰 연구

18세 ~ 130세 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT07124000

A Study on How to Safely Guide Surgery for Melanoma and Similar Skin Tumors in Children Using Pathology and Genetic Information

Nemours Children's Clinic-Jacksonville, Jacksonville
Nemours Children's Hospital, Orlando
Nemours Children's Clinic - Pensacola, Pensacola

피험자 모집 중2상

25세 이하 · 모든 성별 · 2026. 9. 24. 업데이트됨 · NCT07621614

Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.

Orlando Health Cancer Institute, Orlando

피험자 모집 중3상

18세 ~ 70세 · 모든 성별 · 2026. 9. 24. 업데이트됨 · NCT05727904

Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma

Orlando Health Cancer Institute - Lake Mary, Lake Mary
Lakeland Regional Health Hollis Cancer Center, Lakeland
Health Central, Ocoee
외 1개

피험자 모집 중3상

75세 이상 · 모든 성별 · 2026. 9. 24. 업데이트됨 · NCT07068074

Pan-tumor MRD Study

Oncology & Hematology Associates of West Broward, Coral Springs
Mid Florida Cancer Centers, Orange City
Comprehensive Hematology Oncology (CHO), St. Petersburg

피험자 모집 중관찰 연구

18세 이상 · 모든 성별 · 2026. 9. 24. 업데이트됨 · NCT06605404

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

MDR Core Network, Boynton Beach

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 9. 24. 업데이트됨 · NCT06047379

Personalized Cancer Vaccine (PCV) Strategy in Patients With Solid Tumors and Molecular Residual Disease

AdventHealth, Orlando

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 9. 21. 업데이트됨 · NCT06529822

Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

Sylvester Comprehensive Cancer Center - Miami, Miami

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 9. 18. 업데이트됨 · NCT05267626

Adjuvant Therapy Based on Pathologic Response After Neoadjuvant Encorafenib Binimetinib in Melanoma

Moffitt Cancer Center, Tampa

피험자 모집 중초기 1상

18세 이상 · 모든 성별 · 2026. 9. 16. 업데이트됨 · NCT04741997

A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases

Orlando Health Cancer Institute, Orlando
Moffitt Cancer Center-International Plaza, Tampa
Moffitt Cancer Center - McKinley Campus, Tampa
외 1개

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 9. 15. 업데이트됨 · NCT04511013

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

Memorial Healthcare System, Hollywood
The Oncology Institute of Hope & Innovation, Lakeland

피험자 모집 중관찰 연구

18세 이상 · 모든 성별 · 2026. 9. 14. 업데이트됨 · NCT05059444

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Mount Sinai Comprehensive Cancer Center at Aventura, Aventura
Schulze Family Foundation Cancer Clinic - Bonita Health Center, Bonita Springs
Morton Plant Hospital, Clearwater
외 11개

피험자 모집 중관찰 연구건강한 지원자 환영

40세 ~ 75세 · 모든 성별 · 2026. 9. 2. 업데이트됨 · NCT05334069

A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors

Florida Cancer Specialists, Sarasota
Moffitt Cancer Center, Tampa

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 9. 2. 업데이트됨 · NCT07070232

A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors

Mayo Clinic - Florida, Jacksonville
Sarah Cannon Research Institute - Florida Cancer Specialists, Orlando

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 9. 2. 업데이트됨 · NCT04913285

Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer

UM Sylvester Comprehensive Cancer Center at Aventura, Aventura
UM Sylvester Comprehensive Cancer Center at Coral Gables, Coral Gables
UM Sylvester Comprehensive Cancer Center at Deerfield Beach, Deerfield Beach
외 4개

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 8. 31. 업데이트됨 · NCT05896839

Project: Every Child for Younger Patients With Cancer

Broward Health Medical Center, Fort Lauderdale
Golisano Children's Hospital of Southwest Florida, Fort Myers
UF Health Cancer Institute - Gainesville, Gainesville
외 13개

피험자 모집 중관찰 연구

25세 이하 · 모든 성별 · 2026. 8. 25. 업데이트됨 · NCT02402244

Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors

Mayo Clinic in Florida, Jacksonville

피험자 모집 중1/2상

16세 이상 · 모든 성별 · 2026. 8. 20. 업데이트됨 · NCT05269381

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

AdventHealth Celebration, Celebration

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 8. 11. 업데이트됨 · NCT05592626

Nodal Radiation Therapy for Sentinel Lymph Node Positive Melanoma

Baptist - MD Anderson Cancer Center, Jacksonville

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 8. 10. 업데이트됨 · NCT04594187

The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas

Mayo Clinic in Florida, Jacksonville

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 7. 30. 업데이트됨 · NCT07285044

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

Clermont Oncology Center, Clermont
Mid Florida Hematology and Oncology Center, Orange City

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 7. 29. 업데이트됨 · NCT04198766

A Phase 1 of CTX-8371 in Patients With Advanced Malignancies

Florida Cancer Specialists - Lake Nona, Orlando
Florida Cancer Specialists - Sarasota, Sarasota

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 7. 28. 업데이트됨 · NCT06150664

The Florida ASCENT Study

University of Florida, Gainesville

피험자 모집 중

18세 ~ 100세 · 모든 성별 · 2026. 7. 23. 업데이트됨 · NCT07042243

Safety and Efficacy of OBX-115 in Advanced Solid Tumors

Orlando Health Cancer Institute (Melanoma/NSCLC), Orlando

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 7. 16. 업데이트됨 · NCT06060613

Integrated Cancer Repository for Cancer Research

Florida Hospital Memorial Medical Center, Daytona Beach
Florida Hospital DeLand, DeLand
Florida Hospital FISH, Orange City
외 2개

피험자 모집 중관찰 연구건강한 지원자 환영

19세 ~ 110세 · 모든 성별 · 2026. 6. 29. 업데이트됨 · NCT02012699

Clinical Trial of CD40L-augmented TIL for Patients With Advanced Melanoma

Moffitt Cancer Center, Tampa

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 6. 26. 업데이트됨 · NCT06961357

A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer

Sylvester Comprehensive Cancer Center, Miami
Orlando Health Cancer Institute, Orlando
Moffitt Cancer Center, Tampa

피험자 모집 중1/2상

18세 ~ 70세 · 모든 성별 · 2026. 6. 11. 업데이트됨 · NCT05361174

MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid Tumors

Moffitt Cancer Center, Tampa

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 6. 11. 업데이트됨 · NCT05076760

MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma

Mayo Clinic, Jacksonville
University of Miami, Miami
Sarasota Memorial Hospital, Sarasota

피험자 모집 중1/2상

18세 ~ 90세 · 모든 성별 · 2026. 6. 10. 업데이트됨 · NCT05655312

Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program

Mayo Clinic in Florida, Jacksonville

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 6. 9. 업데이트됨 · NCT06265285

DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors

USA08-0, Florida City

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 5. 22. 업데이트됨 · NCT06953089

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

Moffitt Cancer Center, Tampa

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 5. 15. 업데이트됨 · NCT05379985

ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors

University of Miami Hospital and Clinics, Miami

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 5. 13. 업데이트됨 · NCT03686124

Neoadjuvant Darovasertib in Primary Uveal Melanoma

Mayo Clinic Jacksonville, Jacksonville
USF Health Eye Institute, Tampa
Moffit Cancer Center, Tampa

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 5. 6. 업데이트됨 · NCT07015190

A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma

Moffitt Cancer Center, Tampa

피험자 모집 중2/3상

18세 이상 · 모든 성별 · 2026. 4. 22. 업데이트됨 · NCT06624644

A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors

Moffitt Cancer Center, Tampa

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 4. 20. 업데이트됨 · NCT06326411

A Study of VET3-TGI in Patients With Solid Tumors

University of Miami, Miami

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 4. 7. 업데이트됨 · NCT06444815

ClinicalTrials.gov 출처, 2026. 9. 30. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.